The effect of ultrasound-guided transversal-abdominal fascia block combined with nabuphine and dexmedetomidine multi-mode analgesia on cesarean section and postoperative outcomes

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023154

Enrollment

Unknown

Registered

2019-05-14

Start date

2019-05-14

Completion date

Unknown

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean section

Interventions

TAPB combined with DEX and NAB:TAP block was performed before the operation (0.3% ropivacaine +15ug Dexmedetomidine on each side of 25ml), and nalbuphine (1.5mg/kg) PCIA pump was performed after the o

NAB:TAP block was performed before the operation (0.9% Nacl 25ml), and nalbuphine (1.5mg/kg) PCIA pump was performed after the operation

Eligibility

Sex/Gender

Female

Age

21 Years to 50 Years

Inclusion criteria

Inclusion criteria: Choose the parturients intending to perform cesarean section in our hospital, aged 21 to 50 years, ASA I or II level, a single child to full term.

Exclusion criteria

Exclusion criteria: Parturients had severe cardiopulmonary insufficiency, fetal congenital developmental abnormalities, and gestational age <31 weeks.

Design outcomes

Primary

Measure	Time frame
VAS score about incision pain;	—

Countries

China

Contacts

Public ContactShengyou Wang

Hefei Maternal and Child Heath Hospital

hffywsy@sina.com+86 13515659868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026